| Literature DB >> 36039487 |
Zhenqiang Zhang1, Yuan Cheng1, Junjun Ju1, Weichen Shen1, Zhubin Pan1, Yuliang Zhou1.
Abstract
OBJECTIVE: To explore the therapeutic effects of biofeedback in the treatment of faecal incontinence (FI) after surgery for anorectal malformation (ARM).Entities:
Keywords: Biofeedback; anorectal malformation; children; faecal incontinence
Mesh:
Year: 2022 PMID: 36039487 PMCID: PMC9448432 DOI: 10.1080/07853890.2022.2114607
Source DB: PubMed Journal: Ann Med ISSN: 0785-3890 Impact factor: 5.348
The assessment form of St. Mark's incontinence score.
| Never | Seldom | Sometimes | Weekly | Daily | |
|---|---|---|---|---|---|
| Anal incontinence (solid) | 0 | 1 | 2 | 3 | 4 |
| Anal incontinence (liquid) | 0 | 1 | 2 | 3 | 4 |
| Anal incontinence (gas) | 0 | 1 | 2 | 3 | 4 |
| The impact on daily life | 0 | 1 | 2 | 3 | 4 |
| No | Yes | ||||
| The need to wear a pad or plug | 0 | 2 | |||
| The use of constipating medication | 0 | 2 | |||
| The lack of ability to defer defaecation for 15 min. | 0 | 2 |
Note: Never: Never happened within the last four weeks; Seldom: With one occurrence within the last four weeks; Sometimes: With more than one occurrence within the last four weeks; Weekly: Occurred on average once or more per week but on average less than once per day during the last four weeks; Daily: Occurred on average one or more times per day for the last four weeks. The minimum score was 0 point with no faecal incontinence. The maximum score was 24 points with total faecal incontinence.
The general characteristics of the clinical data.
| Item/Group | Group A | Group B | X2 /T |
| |
|---|---|---|---|---|---|
| Age (year) | 8.25 ± 2.84 | 7.00 ± 6.23 | 1.46 | .15 | |
| Gender | Male | 24 | 15 | 0.05 | 1 |
| Female | 4 | 2 | |||
| Bodyweight (Kg) | 22.92 ± 6.23 | 21.23 ± 6.25 | 0.88 | .38 | |
Comparison of the clinical characteristics in the patients between the two groups.
| Item/Group | Group A | Group B | X2/Z/T |
| |
|---|---|---|---|---|---|
| The age at operation | 0.49 ± 0.11 | 0.47 ± 0.11 | 0.56 | .57 | |
| Combined with other deformities | With | 9 | 3 | 1.137 | .286 |
| Without | 19 | 14 | |||
| The duration of symptom (Year) | 2.21 ± 0.71 | 4.14 ± 1.89 | −4.03 | .01 | |
| The anal sphincter integrity | Intact | 16 | 2 | 9.07 | .004 |
| Not-intact | 12 | 15 | |||
| The parameters in anorectal manometry (mmHg) | The anal resting pressure | 27.85 ± 3.45 | 27.35 ± 2.57 | 0.52 | .60 |
| The initial sensitivity threshold | 92.50 ± 5.69 | 90.58 ± 6.34 | 1.04 | .30 | |
| The defaecation sensitivity threshold | 156.78 ± 7.95 | 154.11 ± 8.14 | 1.08 | .28 | |
| The defaecation urge threshold | 209.82 ± 6.30 | 208.82 ± 7.40 | 0.48 | .63 | |
| The incontinence score | 12.95 ± 0.44 | 13.12 ± 0.42 | −1.26 | .21 | |
The assessment of the therapeutic effects.
| Item/Group | Before the treatment | After the treatment | T |
| ||
|---|---|---|---|---|---|---|
| Group A | The parameters in anorectal manometry | The anal resting pressure | 27.85 ± 3.45 | 36.25 ± 2.20 | −12.28 | <.001 |
| The initial sensitivity threshold | 92.50 ± 5.69 | 138.75 ± 7.53 | 12.46 | <.001 | ||
| The defaecation sensitivity threshold | 156.78 ± 7.95 | 135.00 ± 3.04 | 10.56 | <.001 | ||
| The defaecation urge threshold | 209.82 ± 6.30 | 215.89 ± 7.82 | −3.43 | .002 | ||
| The faecal incontinence score | 12.95 ± 0.44 | 3.42 ± 0.47 | 63.08 | <.001 | ||
| Group B | The parameters in anorectal manometry | The anal resting pressure | 27.35 ± 2.57 | 31.23 ± 4.14 | −4.22 | .001 |
| The initial sensitivity threshold | 90.58 ± 6.34 | 135.00 ± 9.35 | −21.65 | <.001 | ||
| The defaecation sensitivity threshold | 154.11 ± 8.14 | 139.70 ± 3.13 | 6.73 | <.001 | ||
| The defaecation urge threshold | 208.82 ± 7.40 | 209.70 ± 7.99 | −0.34 | .73 | ||
| The faecal incontinence score | 13.12 ± 0.42 | 7.29 ± 0.84 | 7.80 | <.001 | ||
The anal sphincter integrity was the influencing factor in the therapeutic effects (Table 6).
The multivariate logistic regression analysis.
| The influencing factor | β | SE | Walds χ2 | OR |
| 95% CI |
|---|---|---|---|---|---|---|
| The anal sphincter integrity | 1.91 | 0.98 | 3.81 | 6.79 | .05 | 0.99–46.45 |
| The duration of symptom | 1.22 | 0.43 | 7.77 | 3.34 | .004 | 1.46–7.90 |
The univariate logistic regression analysis.
| The influencing factor | β | SE | Walds χ2 | OR |
| 95% CI |
|---|---|---|---|---|---|---|
| Age | −0.15 | 0.11 | 1.89 | 0.85 | .16 | 0.68–1.06 |
| Gender | −0.22 | 0.92 | 0.58 | 0.80 | .81 | 0.13–4.91 |
| Bodyweight | −0.46 | 0.05 | 0.78 | 0.95 | .37 | 0.86–1.05 |
| Age at operation | −1.57 | 2.72 | 0.33 | 0.20 | .56 | 0.001–43.23 |
| Comorbidity | −0.79 | 0.75 | 1.10 | 0.45 | .29 | 0.10–1.98 |
| The duration of symptom | 1.34 | 0.43 | 9.63 | 3.83 | .002 | 1.64–8.95 |
| The anal sphincter integrity | 2.30 | 0.84 | 7.44 | 10.00 | .006 | 1.91–52.29 |